Loading...
Strides in GI Cancer Subsets Influence Advances.
Published Jun 20, 2023 02:15PMDr Bose on the Use of Zilurgisertib With/Without Ruxolitinib to Reduce Anemia in Myelofibrosis.
Published Jun 15, 2023 06:33PMPhase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors.
Published Jun 16, 2023 01:17PMBET Inhibition Highlights Exploration of Novel Targeted Approaches in Myelofibrosis.
Published May 26, 2023 06:01PMDr Singer on the Safety of Perioperative Nivolumab and Cabozantinib in RCC.
Published May 18, 2023 10:35PMDr Ryan on the Role of Adjuvant Therapy in RCC.
Published May 12, 2023 11:27PMHsp70 Inhibition Could Help Overcome Belzutifan Resistance in VHL Disease–Associated ccRCC.
Published May 12, 2023 01:29PMRibociclib Plus Letrozole Has Activity in Recurrent Low-Grade Serous Ovarian Cancer.
Published Apr 24, 2023 03:09PMPractice-Changing Trials Expand Armamentarium and Improve Guidance in Advanced Breast Cancers.
Published Apr 13, 2023 01:39PMResearch Clarifies Treatment Patterns and Raises New Questions Across GI Cancers.
Published Mar 23, 2023 07:38PMPrecision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making.
Published Mar 10, 2023 11:18PMDarolutamide Demonstrates Favorable Tolerability, Decreased Metastatic Progression in nmCRPC.
Published Feb 16, 2023 08:47PMFDA Approves Adjuvant Pembrolizumab in NSCLC.
Published Jan 26, 2023 11:03PMNCCN Adds MammaPrint Gene Expression Assay to Breast Cancer Guidelines.
Published Feb 14, 2023 06:06PMDr. Rotroff on Biomarkers Associated With the Risk of Peripheral Neuropathy in Breast Cancer.
Published Jan 25, 2023 10:28PMDr. Herbst on the FDA Approval of Adjuvant Pembrolizumab in NSCLC.
Published Feb 02, 2023 07:52PMCombinations Targeting EGFR and KRAS G12C May Advance NSCLC Treatment.
Published Feb 02, 2023 07:17PMDr. Flinn on the FDA Approval of Zanubrutinib in CLL/SLL.
Published Jan 25, 2023 04:17AMDr. Stanton on Improving Responses to Immunotherapy in Early-Stage HR+ Breast Cancer.
Published Jan 25, 2023 01:34PMDr. Vicini on the Potential Utility of the DCISionRT Test in HER2+ DCIS of the Breast.
Published Jan 25, 2023 01:48PMThe site is protected by reCAPTCHA
Help onclive reach the Founder Status of the WikiXM Phoenix News.
https://wikixm.com/register/ b36ed8a07e3cd80ee37138524690eca1
The site is protected by reCAPTCHA
WikiXM use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Read more about cookies here
Introducing Your Local Garage where you can post and sell everything you have wanted to sell.
Post upto 5 items for free. After that it's just $20 a year to post up to 50 items in your own Garage.
Directly Communicate with buyers.
Get direct feedback from Buyers to improve your postings.
Receive updates and reminders on items posted but not sold to improve sales.
Selling analytics
Your Garage will come with more selling features to help you get your items sold fast!
The site is protected by reCAPTCHA
You need to verify your email to proceed
The site is protected by reCAPTCHA
The site is protected by reCAPTCHA
Welcome to WikiXM. Become the voice of your town.
Sign up now
The site is protected by reCAPTCHA
WikiXM is a local news platform that brings local news back to your town. WikiXM is where users can create, discuss and read the news that's important to them. Your town has 1000's of activities going on every day, with many different viewpoints that make your town unique. On WikiXM, viewers can create articles, read, comment and contribute to other articles to bring out viewpoints that make your town unique. Our goal is to enable each town to gain full insight into every aspect of the news and topics that are impacting it. WikiXM is where civil conversation can be had and insight gained.
The WikiXM news platform promotes the local user audience to monitor the news in ways that fits each town's needs. The users monitor and help keep content civil by a flagging and rating system that promotes positive activity and demotes or removes negative activity.
We also promote those that initiate their towns WikiXM news site through our founder pages. The Founders are forever kept on the town's founder pages and are promoted on a frequent basis.
WikiXM promotes reporters that the town reads and rates highly. Reporters will be highlighted and given higher article ranking as they build their following and ranking. Reporters that achieve certain status levels will be given more privileges and greater status within their town's platform.
As WikiXM grows, articles will achieve higher levels of readership and geography. Whats discussed in one town may be important in others regardless of location. Our goal is to make our reporters rock stars!
There are a million interesting topics going on in your town today, report and discuss them on WikiXM. One day, the world may be following you.
The site is protected by reCAPTCHA
Town Requested
The site is protected by reCAPTCHA
The site is protected by reCAPTCHA
Welcome to , town news page.
The site is protected by reCAPTCHA
Welcome to WikiXM. Become the voice of your town.
Sign up as a reporter
The site is protected by reCAPTCHA